Last updated on November 2017

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of LX-4211 as Adjunct Therapy in Adult Patients with Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control


Brief description of study

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of LX-4211 as Adjunct Therapy in Adult Patients with Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control

Detailed Study Description

Evaluate LX4211 in type 1 patients with poorly controlled blood sugars.

Clinical Study Identifier: TX7694

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Baylor Scott & White Research ...

Baylor Scott & White Research Institute
Dallas, TX USA
  Connect »